Parkinsonism — reduced rigidity, improved walking and clearer speech

👤 Patient Profile: Franco Bonifazi, 81 — Italy

Diagnosis: Parkinsonism

Franco, an 81-year-old man from Italy, was diagnosed with Parkinsonism. By early 2025, he was experiencing significant rigidity, balance issues, reduced mobility, and cognitive decline.

🧬 Clinical Approach at BioCells Medical

In March 2025, Franco began an allogeneic regenerative therapy protocol at BioCells Medical. The programme included:

• Placenta-derived MSCs (cells and exosomes)

• T-regulatory cells derived from cord blood

• Intravenous and intranasal administration over two days

• Two sessions of Electro-Neuro Therapy (ENT)

• A personalised exercise plan developed by a rehabilitation specialist

Observed results after the first cycle:

• Reduced rigidity

• Increased walking capacity

• Improved cognitive function

In May 2025, a second cycle of therapy was performed. The protocol used the same cellular products but included intrathecal administration and a slightly higher cell dose.

📈 Observed Results

Following the second cycle, Franco’s family reported:

• Noticeably clearer, faster, and more coherent speech

• Continued improvements in motor capacity and cognition

Due to ongoing balance difficulties associated with Parkinsonism, his rehabilitation plan was updated after the second cycle to further support gait and stability.

🔁 Follow-Up

Franco is currently under medical observation, with sustained improvements and an adjusted programme of exercises. Further treatment cycles will be considered depending on clinical evolution and family goals.

📩 Explore Your Options If your loved one is living with Parkinson’s or atypical parkinsonism, personalised regenerative protocols may offer meaningful improvements.→ Book a free online consultation with our doctors to discuss your case.